518 related articles for article (PubMed ID: 25886765)
1. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis.
Van der Linden P; Dumoulin M; Van Lerberghe C; Torres CS; Willems A; Faraoni D
Crit Care; 2015 Mar; 19(1):87. PubMed ID: 25886765
[TBL] [Abstract][Full Text] [Related]
2. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
[TBL] [Abstract][Full Text] [Related]
3. Colloids in Cardiac Surgery-Friend or Foe?
Ryhammer PK; Tang M; Hoffmann-Petersen J; Leonaviciute D; Greisen J; Storebjerg Gissel M; Jakobsen CJ
J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1639-1648. PubMed ID: 28372955
[TBL] [Abstract][Full Text] [Related]
4. The effect of intraoperative 6% balanced hydroxyethyl starch (130/0.4) during cardiac surgery on transfusion requirements.
Hans GA; Ledoux D; Roediger L; Hubert MB; Koch JN; Senard M
J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):328-32. PubMed ID: 25440623
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery.
Skhirtladze K; Base EM; Lassnigg A; Kaider A; Linke S; Dworschak M; Hiesmayr MJ
Br J Anaesth; 2014 Feb; 112(2):255-64. PubMed ID: 24169821
[TBL] [Abstract][Full Text] [Related]
6. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
[TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
8. Albumin utilization in cardiac surgery after transition to hydroxyethyl starch 130/0.4.
Romerill DB; Toyoda AY; Brodeur BE; Moellentin D
J Pharm Pract; 2012 Dec; 25(6):606-10. PubMed ID: 22797837
[TBL] [Abstract][Full Text] [Related]
9. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler JO
Braz J Anesthesiol; 2013 Jan; 63(1):27-35. PubMed ID: 24565088
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
11. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.
Vogt NH; Bothner U; Lerch G; Lindner KH; Georgieff M
Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study.
Lagny MG; Roediger L; Koch JN; Dubois F; Senard M; Donneau AF; Hubert MB; Hans GA
J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):869-75. PubMed ID: 26774199
[TBL] [Abstract][Full Text] [Related]
13. Postoperative renal morbidity and mortality after volume replacement with hydroxyethyl starch 130/0.4 or albumin during surgery: a propensity score-matched study.
Miyao H; Kotake Y
J Anesth; 2020 Dec; 34(6):881-891. PubMed ID: 32783070
[TBL] [Abstract][Full Text] [Related]
14. Balanced 10% hydroxyethyl starch compared with balanced 6% hydroxyethyl starch and balanced crystalloid using a goal-directed hemodynamic algorithm in pancreatic surgery: A randomized clinical trial.
Werner J; Hunsicker O; Schneider A; Stein H; von Heymann C; Freitag A; Feldheiser A; Wernecke KD; Spies C
Medicine (Baltimore); 2018 Apr; 97(17):e0579. PubMed ID: 29703051
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of peri-operative administration of hydroxyethyl starch in children undergoing surgery: A systematic review and meta-analysis.
Thy M; Montmayeur J; Julien-Marsollier F; Michelet D; Brasher C; Dahmani S; Orliaguet G
Eur J Anaesthesiol; 2018 Jul; 35(7):484-495. PubMed ID: 29419565
[TBL] [Abstract][Full Text] [Related]
16. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis*.
Bayer O; Schwarzkopf D; Doenst T; Cook D; Kabisch B; Schelenz C; Bauer M; Riedemann NC; Sakr Y; Kohl M; Reinhart K; Hartog CS
Crit Care Med; 2013 Nov; 41(11):2532-42. PubMed ID: 23978813
[TBL] [Abstract][Full Text] [Related]
17. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery.
Boldt J; Schölhorn T; Mayer J; Piper S; Suttner S
Anesth Analg; 2006 Jul; 103(1):191-9, table of contents. PubMed ID: 16790652
[TBL] [Abstract][Full Text] [Related]
18. Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery.
Miao N; Yang J; Du Z; Liu W; Ni H; Xing J; Yang X; Xu B; Hou X
Perfusion; 2014 Sep; 29(5):462-8. PubMed ID: 24658707
[TBL] [Abstract][Full Text] [Related]
19. Effects of Perioperative Fluid Replacement Therapy in Lung Transplant Patients.
Björkbom E; Hämmäinen P; Schramko A
Exp Clin Transplant; 2017 Feb; 15(1):78-81. PubMed ID: 27855591
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.
He B; Xu B; Xu X; Li L; Ren R; Chen Z; Xiao J; Wang Y; Xu B
Crit Care; 2015 Mar; 19(1):92. PubMed ID: 25886952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
